These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 43704)

  • 21. Neurotransmitters may be weak link in the aging brain's communication network.
    Kent S
    Geriatrics; 1976 Jul; 31(7):105-11. PubMed ID: 7512
    [No Abstract]   [Full Text] [Related]  

  • 22. Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases.
    Nagatsu T; Yamaguchi T; Rahman MK; Trocewicz J; Oka K; Hirata Y; Nagatsu I; Narabayashi H; Kondo T; Iizuka R
    Adv Neurol; 1984; 40():467-73. PubMed ID: 6141712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A 78-year-old man with young onset parkinsonism and sudden death].
    Miyasaka H; Mori H; Saikawa T; Shirai T; Kondo T; Imai H; Mizuno Y
    No To Shinkei; 1996 May; 48(5):487-95. PubMed ID: 8672309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese family with parkinsonism, depression, weight loss, and central hypoventilation.
    Tsuboi Y; Wszolek ZK; Kusuhara T; Doh-ura K; Yamada T
    Neurology; 2002 Apr; 58(7):1025-30. PubMed ID: 11940687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism.
    Melamed E; Hefti F; Wurtman RJ
    Ann Neurol; 1980 Dec; 8(6):558-63. PubMed ID: 6260009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The content of dopamine, its metabolites and GABA in the nigrostriatal system of rats with different learning abilities].
    Karpova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):161-3. PubMed ID: 1316006
    [No Abstract]   [Full Text] [Related]  

  • 27. Dominantly inherited dementia and parkinsonism, with non-Alzheimer amyloid plaques: a new neurogenetic disorder.
    Rosenberg RN; Green JB; White CL; Sparkman DR; DeArmond SJ; Kepes JJ
    Ann Neurol; 1989 Feb; 25(2):152-8. PubMed ID: 2645825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].
    Ugriumov MV
    Usp Fiziol Nauk; 2007; 38(4):3-20. PubMed ID: 18064905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
    Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
    J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early-onset parkinsonism with diurnal fluctuation--clinical and pathological studies].
    Yamamura Y; Arihiro K; Kohriyama T; Nakamura S
    Rinsho Shinkeigaku; 1993 May; 33(5):491-6. PubMed ID: 8365054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopaminergic responses to striatal damage.
    Howells DW; Liberatore GT; Wong JY; Donnan GA
    J Neurol Sci; 1996 Jul; 139(1):125-30. PubMed ID: 8836983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in research on Parkinsonism.
    Rinne UK
    Acta Neurol Scand Suppl; 1978; 67():77-113. PubMed ID: 31053
    [No Abstract]   [Full Text] [Related]  

  • 37. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of reserpine on activities and amounts of tyrosine hydroxylase and dopamine-beta-hydroxylase in catecholamine neuronal systems in rat brain.
    Reis DJ; Joh TH; Ross RA
    J Pharmacol Exp Ther; 1975 Jun; 193(3):775-84. PubMed ID: 239215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management.
    Roy EP; Riggs JE; Martin JD; Ringel RA; Gutmann L
    Neurology; 1988 Apr; 38(4):637-9. PubMed ID: 3352925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical evaluation of the postmortem factors influencing neurochemical analyses of brain autopsies.
    Röytta M; Laaksonen H; Frey H; Riekkinen P; Rinne UK
    Acta Neurol Scand; 1980 Feb; 61(2):88-106. PubMed ID: 6104885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.